Bioscience & Health Care

The University advances innovation in bioscience and health care delivery by supporting research and sustained growth for startups and bioscience initiatives. Partnerships with powerful industry leaders like INOVA create impact throughout the state and beyond.

Filter by Region, Sector, or Focus
Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.
An app designed by researchers at the University of Virginia is proving that 'warm technology' - personalized and personal - can have an impact on patient engagement and care management.
Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).
The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.
Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.
Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).
Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.
Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.
The University has approved an academic affiliation with INOVA Health System and George Mason University.
UVA helps address the opioid crisis by dedicating expertise and resources from an array of disciplines to tackle the problem throughout the state, including Virginia's most rural areas.